Ascentage Pharma is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies and is in the process of conducting more than 40 clinical trials in specific regions worldwide. Ascentage Pharma has been listed on the Main Board of the HKEX with the stock code 6855.HK since October 2019 and recently listed in NASDAQ in January 2025 under the stock code AAPG.
Looking for a particular Ascentage Pharma employee's phone or email?
Ascentage Pharma Questions
The Ascentage Pharma annual revenue was $80.9 million in 2026.
Yifan Zhai is the Chief Medical Officer of Ascentage Pharma.
137 people are employed at Ascentage Pharma.
The NAICS codes for Ascentage Pharma are [54171, 325, 3254, 5417, 541711, 541, 32, 54].
The SIC codes for Ascentage Pharma are [283, 28, 80].
Top Ascentage Pharma Employees
-
Yifan Zhai
Chief Medical Officer at Ascentage Pharma
Rockville, MD, US25+ -
Yifan Zhai
Chief Medical Officer at Ascentage Pharma
Rockville, MD, US25+ -
25+ -
22 -
John Tang
VP, Global Head of Program Management at Ascentage Pharma
New York, NY, US12 -
Veet Misra
Chief Financial Officer at Ascentage Pharma
San Francisco, CA, US3
Related Companies
